Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin condition called linear lichen planopilaris caused itchy red bumps and hair loss on a man's face.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A rare skin disorder affecting the face was found in a 28-year-old Saudi man.

Many research paper titles in dermatology journals lack scientific precision.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

The patient had a severe itchy rash and hair loss in the armpits.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Porokeratotic eccrine and hair follicle nevus is a very rare skin disorder possibly caused by a GJB2 gene mutation.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.